Geffy 250 mg Tablet
$48,39
$12,23
Geffy 250 mg Tablet is an effective treatment option for adults diagnosed with advanced non-small cell lung cancer (NSCLC) that has metastasized and is linked to mutations in the EGFR gene. This targeted therapy works by inhibiting the activity of specific proteins that promote cancer cell growth, thereby slowing down the progression of the disease. It is essential to note that Geffy is not approved for use in children or adolescents, as the safety and efficacy of this medication in younger patients remain unclear. While many patients experience positive outcomes, potential side effects may occur, and monitoring by a healthcare professional is crucial during treatment. Before starting Geffy, discuss your complete medical history with your doctor to ensure it is the right fit for you. This medication should only be taken under strict medical supervision, and patients must adhere to their prescribed treatment regimen for optimal results. If you experience any unusual symptoms while using Geffy, contact your healthcare provider promptly. By addressing the unique genetic aspects of NSCLC, Geffy 250 mg Tablet represents a personalized approach to cancer care that aims to improve patient outcomes.
數量
Active Pharmaceutical Ingredient
Uses
• Geffy 250 mg tablet is primarily used for the treatment of non-small cell lung cancer (NSCLC). This type of lung cancer affects a large number of cells in the lung tissue. By targeting specific pathways involved in tumor growth, Geffy helps to inhibit the progression of the disease. Patients receiving this medication may experience an improvement in their overall condition.
• In clinical practice, Geffy 250 mg tablet is utilized when other treatment options are not suitable for patients with advanced non-small cell lung cancer. It can be part of a comprehensive treatment plan, often in conjunction with other therapies. This approach allows for a more tailored strategy to manage the disease effectively. The use of Geffy aims to enhance the quality of life for patients facing this challenging diagnosis.
• Healthcare providers may prescribe Geffy 250 mg tablet to patients with specific genetic markers associated with non-small cell lung cancer. The medication works by targeting these markers, thereby potentially increasing the effectiveness of treatment. This personalized approach can lead to better outcomes for individuals with particular cancer profiles. As a result, Geffy plays a vital role in modern oncology practices.
• Patients may also find Geffy 250 mg tablet beneficial in managing symptoms related to non-small cell lung cancer. The medication is designed to help control tumor growth, which can alleviate discomfort and improve respiratory function. By integrating Geffy into their treatment regimen, patients may experience a reduction in the severity of their symptoms. This can contribute to a more manageable daily life while undergoing cancer treatment.
Benefits
Gefitinib Tablet 250 mg inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Geffy Tablet may help to slow the progression of cancer.
Geffy 250 mg may help reduce the severity of cancer-related symptoms, such as pain and fatigue, which can improve a patient's overall quality of life.
Gefitinib Tablet 250 mg may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.
Side Effects
As with all medicines, Geffy 250 mg Strip may cause some side effects. If you experience any of these side effects, you should contact your doctor or health care professional as soon as possible. Your doctor may be able to suggest ways in which these side effects can be managed or the severity of them reduced.
Most Common Side Effects
• Tremor
• Hypertension
• Headache
• Increased Potassium levels in the blood
• Hypertension
• Gastrointestinal problems
• Abnormal Growth of Hair
Common Side Effects
• Liver Damage
• Seizures

